Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha1-adrenergic receptor antagonist, trimazosin, in hypertension

[1]  A. Donker,et al.  Pharmacokinetics of trimazosin and its effects on blood pressure, renal function and proteinuria during short-term therapy of patients with impaired renal function and hypertension , 2004, European Journal of Clinical Pharmacology.

[2]  P. Weidmann,et al.  Alpha‐1‐adrenergic blockade and lipoprotein metabolism in essential hypertension , 1986, Clinical pharmacology and therapeutics.

[3]  R. Weeks,et al.  The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade. , 1984, Journal of cardiovascular pharmacology.

[4]  P. Meredith,et al.  Pharmacokinetics and pharmacodynamics of trimazosin in man. , 1983, American heart journal.

[5]  P. D. de Leeuw,et al.  Opening remarks: mismatch of essential hypertension's pathophysiology and current antihypertensive drugs: a perspective for alpha-1-adrenergic blockade. , 1983, American heart journal.

[6]  J. Leader,et al.  Profile of trimazosin: an effective and safe antihypertensive agent. , 1983, American heart journal.

[7]  A. Salel,et al.  Clinical hemodynamic profile of trimazosin in hypertension. , 1983, American heart journal.

[8]  S. Chrysant.  Autonomic, systemic, and renal hemodynamic actions of trimazosin in hypertensive patients. , 1983, American heart journal.

[9]  S. Chrysant,et al.  Long‐term hemodynamic and metabolic effects of trimazosin in essential hypertension , 1981, Clinical pharmacology and therapy.

[10]  J. Buyniski,et al.  Effects of tiodazosin, praxosin, trimazosin and phentolamine on blood pressure, heart rate and on pre- and postsynaptic alpha-adrenergic receptors in the rat. , 1980, Clinical and experimental hypertension.

[11]  N. Norman,et al.  Central and renal circulation, renin and aldosterone in plasma during prazosin treatment in essential hypertension. , 2009, Acta medica Scandinavica.

[12]  D. Mason,et al.  Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure. , 1979, The American journal of cardiology.

[13]  D. Richards,et al.  Circulatory and alpha-adrenoceptor blocking effects of phentolamine. , 1978, British journal of clinical pharmacology.

[14]  M. Schoog,et al.  [Prazosin, a new antihypertensive agent]. , 1978, Wiener medizinische Wochenschrift.

[15]  J. Tobis,et al.  Comparison of trimazosin and methyldopa in hypertension , 1977, Clinical pharmacology and therapeutics.

[16]  J. Walker,et al.  SELECTIVITY OF BLOCKING AGENTS FOR PRE‐ AND POSTSYNAPTIC α‐ADRENOCEPTORS , 1977 .

[17]  G. Stokes,et al.  Mechanism of the hypotensive action of prazosin. , 1977, Archives internationales de pharmacodynamie et de therapie.

[18]  D Cambridge,et al.  Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings]. , 1977, British journal of pharmacology.

[19]  J. Walker,et al.  Selectivity of blocking agents for pre-and postsynaptic alpha-adrenoceptors. , 1977, British journal of pharmacology.

[20]  Matthews Sj.  Prazosin: a new antihypertensive agent. , 1978, Drug and therapeutics bulletin.

[21]  N. Vlachakis,et al.  Treatment of essential hypertension with trimazosin, a new vasodilator agent. , 1975, Current therapeutic research, clinical and experimental.

[22]  N. Vlachakis,et al.  The effect of trimazosin in essential hypertension. , 1973, Current therapeutic research, clinical and experimental.

[23]  J. Moyer,et al.  The clinical results of oral and parenteral administration of 2-(N'p-tolyl-N'-m-hydroxyphenylaminomethyl) imidazoline hydrochloride (regitine) in the treatment of hypertension and an evaluation of the cerebral hemodynamic effects. , 1953, American heart journal.